Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone + Nepafenac vs Triamcinolone for Diabetic Macular Edema
NCT00780780Phase 3Completed
- Sponsor
- Federal University of São Paulo
- Start
- Jul 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nepafenac in diabetic macular edema (DME), sponsored by Federal University of São Paulo. Started Jul 2007; status: completed.
02
Drugs
nepafenac
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00780780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780780.